Operating cash flow decreased 32.4%
Operating cash flow changed -32.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed -32.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed -38.3% from the comparable as-filed period.
Operating margin changed -1588 basis points from the comparable as-filed period.
Net income changed -54.4% from the comparable as-filed period.
Gross margin changed -430 basis points from the comparable as-filed period.
Cash & equivalents changed +99.3% from the comparable as-filed period.
Research & development changed +43.6% from the comparable as-filed period.
SBC / revenue changed +848 basis points from the comparable as-filed period.
Stock-based compensation changed +68.1% from the comparable as-filed period.
Trade receivables changed +25.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.